When BioNukleo was founded in 2014 as a spin-off of the Department of Bioprocess Engineering of the Technische Universität Berlin, we were already looking back on years of academic research on enzymatic production of nucleosides and the production of difficult-to express proteins.
Since then BioNukleo has developed into a specialist in biocatalysis and its applications in the synthesis of nucleoside and nucleotide derivatives and other fine chemicals.
We are a growing team of young and aspiring scientists and engineers with backgrounds in biology, biotechnology, biochemistry, chemistry, bioinformatics, and pharmaceutical sciences. With the youthful agility and flexibility of a young team and our unwavering commitment to scientific excellence we are able to provide cutting-edge solutions that are tailored to meet the specific needs of our customers.
Our advisory board consists of Prof. Dr. Peter Neubauer, full professor for Bioprocess Engineering at the TU Berlin, and Prof. Jens Kurreck, full professor of Applied Biochemistry at the TU Berlin.
Key aspects of Peter Neubauer's research are the development and application of new methods for faster bioprocess development - including genetic, cultivation, and analytical tools. A special focus lies on up- and down-scaling between lab and industrial scale. He is author of >200 publications in peer-reviewed journals and holds over 10 patents. He is founder/cofounder of several companies (e.g. Scanbec, Enpresso, Celltainer biotech).
The research of Jens Kurreck focuses on nucleic acid technologies, organ models, pain research and virology. He has published more than 80 papers in peer-reviewed journals.
BioNukleo is located in Germany's beautiful capital city Berlin. In addition to the rich culture and high quality of life, the city captivates with its high density and excellence of research and academic institutions as well as clinics. The German capital region is one of the world's leading locations in healthcare and life science innovation. More than 500 biotech, pharma, and medtech companies benefit from the highly-qualified workforce and the excellent networking between science, clinics and business.
Directly on the campus of the Technische Universität Berlin in Wedding - with its chairs of Bioprocess Engineering and Applied Biochemistry (among others) - BioNukleo can profit from a stimulating research environment as well as short paths to exchanges and partnerships, specialised facilities and expertise.
You can easily reach us by public transportation with bus number 247 (to Gartenplatz), tram M10 (to Gedenkstätte Berliner Mauer), subway U8 (to Voltastraße) or the interurban trains S1, S2, S25, S26 (to Nordbahnhof/Humboldthain).